An immune-related model based on INHBA, JAG2 and CCL19 to predict the prognoses of colon cancer patients release_uc55udy4xfctngvxypkiwvz5eu

by Xuankun Yang, Jia Yan, Yahui Jiang, Yaxu Wang

Published in Cancer Cell International by Springer Science and Business Media LLC.

2021   Volume 21, Issue 1, p299

Abstract

<jats:title>Abstract</jats:title><jats:sec> <jats:title>Background</jats:title> Colorectal cancer (CRC) is the leading cause of cancer deaths and most common malignant tumors worldwide. Immune-related genes (IRGs) can predict prognoses of patients and the effects of immunotherapy. A series of colon cancer (CCa) samples from The Cancer Genome Atlas (TCGA) were analyzed to provide a new perspective into this field. </jats:sec><jats:sec> <jats:title>Methods</jats:title> Differential IRGs and IRGs with significant clinical outcomes (sIRGs) were calculated by the limma algorithm and univariate COX regression analysis. The potential molecular mechanisms of IRGs were detected by PPI, KEGG and GO analysis. Immune-related risk score model (IRRSM) was established based on multivariate COX regression analysis. Based on the median risk score of IRRSM, the high-risk group and low-risk group were distinguished. The expression levels of IHNBA and JAG2 and relationships between IHNBA and clinical features were verified by RT-qPCR. </jats:sec><jats:sec> <jats:title>Results</jats:title> 6 differential sIRGs of patients with CCa were selected by univariate COX regression analysis. Based on the sIRGs (INHBA, JAG2 and CCL19), the IRRSM was established to predict survival probability of CCa patients and to explore the potential correlations with clinical features. Furthermore, IRRSM reflected the infiltration status of 22 types of immune cells. The expression levels of IHNBA and JAG2 were higher in CCa tissues than that in adjacent normal tissues. The expression levels of IHNBA and JAG2 were increased in advanced T stages. </jats:sec><jats:sec> <jats:title>Conclusion</jats:title> Our results illustrated that some sIRGs showed the latent value of predicting the prognoses of CCa patients and the clinical features. This study could provide a new insight for immune research and treatment strategies in CCa patients. </jats:sec>
In application/xml+jats format

Archived Files and Locations

application/pdf   4.7 MB
file_7trpnbievvayngqdc7f3pn2ojm
cancerci.biomedcentral.com (publisher)
web.archive.org (webarchive)
Read Archived PDF
Preserved and Accessible
Type  article-journal
Stage   published
Date   2021-06-08
Language   en ?
Container Metadata
Open Access Publication
In DOAJ
In ISSN ROAD
In Keepers Registry
ISSN-L:  1475-2867
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
Catalog Record
Revision: 6f9eae66-0863-4655-9bfb-0a53091a23ab
API URL: JSON